These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6342128)

  • 1. Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women.
    Ahlmén J; Sigurdsson J; Wohrm A; Calmenius C; Merck C; Bucht H
    Scand J Infect Dis; 1983; 15(1):71-4. PubMed ID: 6342128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nalidixic acid plus sodium citrate twice daily in the treatment of acute urinary tract infection. Swedish Collaborative Study Group.
    Scand J Prim Health Care; 1988 Feb; 6(1):59-63. PubMed ID: 3281205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance.
    Cederberg A; Denneberg T; Ekberg M; Juhlin I
    Scand J Infect Dis; 1974; 6(3):259-64. PubMed ID: 4607842
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.
    Atlas E; Clark H; Silverblatt F; Turck M
    Ann Intern Med; 1969 Apr; 70(4):713-21. PubMed ID: 4977045
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of ampicillin and nalidixic acid in the treatment of urinary tract infections caused by E. coli.
    Toivonen S; Pentikäinen P; Leirisalo M; Pyörälä K
    Acta Med Scand; 1974 Mar; 195(3):181-4. PubMed ID: 4595253
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience of three-day trimethoprim therapy for dysuria-frequency in primary health care.
    Ahlmén J; Frisén J; Ekbladh G
    Scand J Infect Dis; 1982; 14(3):213-6. PubMed ID: 6755659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of simple urinary tract infections in general practice with a 3-day course of norfloxacin.
    Kirby CP
    J Antimicrob Chemother; 1984 May; 13 Suppl B():107-12. PubMed ID: 6234270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nalidixic acid by intravenous infusion. A report of 50 cases.
    Economou G; Macis R; Ward-McQuaid N
    Br J Urol; 1972 Aug; 44(4):503-9. PubMed ID: 4560832
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
    Bucy JG
    J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
    Briedigkeit H; Schimmelpfennig R; Buder R; Precht K; Dröseler H
    Infection; 1982; 10(4):219-22. PubMed ID: 7129643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nalidixic acid in urinary infection.
    Neogy KN; De MS; Chatterjee ML
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):11-2. PubMed ID: 4890385
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy results with nalidixic acid in chronic urinary tract infection].
    Broghammer H
    Arzneimittelforschung; 1968 Sep; 18(9):1139-43. PubMed ID: 4885373
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-day course of antibacterials for uncomplicated urinary infections.
    Rosen DI
    Urology; 1976 Nov; 8(5):450-1. PubMed ID: 790745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term nalidixic acid plus sodium citrate in acute lower urinary tract infection.
    Ferry S; Burman LG; Widberg B; Calmenius C
    Scand J Infect Dis; 1987; 19(4):469-77. PubMed ID: 3672052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
    Yamasaki I; Kato T; Ogawa T
    Hinyokika Kiyo; 1965 Sep; 11(9):913-34. PubMed ID: 5324475
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
    Brown PC; Donaghy MC; Dootson PH; Titcombe DH; MacLaren DM
    Practitioner; 1971 Dec; 207(242):819-26. PubMed ID: 4947233
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical use of Wintomylon (nalidixic acid) in the field of urology].
    Gotoh K; Shinoda T; Ito S; Isogai K; Kimura T; Ohtani F; Ishiyama K
    Hinyokika Kiyo; 1965 Oct; 11(10):1011-4. PubMed ID: 5324357
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characterization and antimicrobial resistance of Escherichia coli in pediatric patients with urinary tract infection at a third level hospital of Quito, Ecuador.
    Garrido D; Garrido S; Gutiérrez M; Calvopiña L; Harrison AS; Fuseau M; Salazar Irigoyen R
    Bol Med Hosp Infant Mex; 2017; 74(4):265-271. PubMed ID: 29382515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection.
    Greenwood D; Andrew J
    J Antimicrob Chemother; 1978 Nov; 4(6):533-8. PubMed ID: 101503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.